Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedNov 14, 2025
DataAggregated Company Financials
Companies6
- 7D-1.0%
- 3M-8.4%
- 1Y-18.8%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 1.0%, driven by Celon Pharma declining 1.4%. However, the industry is down 19% over the past year. Looking forward, earnings are forecast to grow by 40% annually.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 15 Nov 2025 | zł1.4b | zł328.1m | -zł92,032,830.00 | 9.1x | -14.8x | 4.2x |
| Mon, 13 Oct 2025 | zł1.5b | zł327.7m | -zł93,055,146.00 | 10.1x | -15.8x | 4.5x |
| Wed, 10 Sep 2025 | zł1.4b | zł333.9m | -zł72,252,084.00 | 10.3x | -19.9x | 4.3x |
| Fri, 08 Aug 2025 | zł1.5b | zł333.7m | -zł73,417,994.00 | 12.6x | -20x | 4.4x |
| Sun, 06 Jul 2025 | zł1.5b | zł333.7m | -zł73,417,994.00 | 13.8x | -20.7x | 4.5x |
| Tue, 03 Jun 2025 | zł1.4b | zł333.7m | -zł73,417,994.00 | 16.4x | -19.4x | 4.3x |
| Thu, 01 May 2025 | zł1.7b | zł324.0m | -zł12,792,856.00 | 46x | -130.7x | 5.2x |
| Sat, 29 Mar 2025 | zł1.7b | zł322.6m | -zł12,258,563.00 | 46.5x | -139.7x | 5.3x |
| Mon, 24 Feb 2025 | zł1.5b | zł322.2m | -zł10,142,168.00 | 40.2x | -145.9x | 4.6x |
| Wed, 22 Jan 2025 | zł1.6b | zł318.9m | -zł9,295,998.00 | 42.9x | -174.3x | 5.1x |
| Fri, 20 Dec 2024 | zł1.6b | zł318.9m | -zł9,295,998.00 | 41.9x | -174.7x | 5.1x |
| Sun, 17 Nov 2024 | zł1.6b | zł314.5m | -zł72,767,518.00 | 10.3x | -22.6x | 5.2x |
| Tue, 15 Oct 2024 | zł1.8b | zł314.9m | -zł72,051,939.00 | 10.1x | -25.4x | 5.8x |
| Thu, 12 Sep 2024 | zł1.8b | zł317.3m | -zł60,178,104.00 | 11.9x | -30.1x | 5.7x |
| Sat, 10 Aug 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 11.7x | -28.9x | 5.7x |
| Mon, 08 Jul 2024 | zł1.1b | zł310.8m | -zł61,217,640.00 | 11.3x | -18.1x | 3.6x |
| Wed, 05 Jun 2024 | zł1.1b | zł312.1m | -zł61,350,052.00 | 11.4x | -18.7x | 3.7x |
| Fri, 03 May 2024 | zł1.1b | zł313.6m | -zł43,157,065.00 | 15.1x | -26.4x | 3.6x |
| Sun, 31 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.5x | -29.1x | 3.8x |
| Tue, 27 Feb 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.7x | -30x | 3.9x |
| Thu, 25 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 12.8x | -29.2x | 3.8x |
| Sat, 23 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -29.9x | 3.9x |
| Mon, 20 Nov 2023 | zł1.1b | zł302.0m | -zł45,017,759.00 | 12.4x | -24.5x | 3.7x |
| Wed, 18 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.2x | 3.7x |
| Fri, 15 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 11.2x | -21.9x | 4.1x |
| Sun, 13 Aug 2023 | zł1.1b | zł277.2m | -zł53,957,528.00 | 11.5x | -21.1x | 4.1x |
| Tue, 11 Jul 2023 | zł1.1b | zł278.4m | -zł53,806,540.00 | 37.5x | -20.4x | 3.9x |
| Thu, 08 Jun 2023 | zł1.2b | zł282.1m | -zł51,108,194.00 | 34.6x | -23x | 4.2x |
| Sat, 06 May 2023 | zł1.1b | zł276.0m | -zł51,431,989.00 | 9.1x | -21.3x | 4x |
| Mon, 03 Apr 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.4x | -25.6x | 4.2x |
| Wed, 01 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -25.3x | 4.1x |
| Fri, 27 Jan 2023 | zł1.2b | zł270.3m | -zł44,201,704.00 | 8.1x | -26.3x | 4.3x |
| Sun, 25 Dec 2022 | zł971.4m | zł270.3m | -zł44,201,704.00 | 8x | -22x | 3.6x |
| Tue, 22 Nov 2022 | zł1.0b | zł260.9m | -zł40,809,798.00 | 8.1x | -24.7x | 3.9x |
Price to Earnings Ratio
-24.7x
Current Industry PE
- Investors are relatively neutral on the Polish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
- Meanwhile revenues for these companies have grown 7.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.
Industry Comparison
How does Polish Pharma compare with similar industries?
| PL Market | 0.89% | |
| Healthcare | -0.55% | |
| Pharma | -1.02% | |
| Pharma | -1.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BGD Biogened | zł21.80 | 2.8% +zł1.5m | -2.7% | PE9.2x | |
| GRZ Green Zebras Spolka Akcyjna | zł9.80 | 7.7% +zł929.5k | -29.1% | PS13.5x |